Targeted Oncology

CD25 Biology Opens Doors to Innovative AML/ALL Treatments

CD25 rewires oncogene signaling in AML and ALL, revealing druggable complexes and a bold strategy: push pathways into toxic ...
Targeted Oncology

The Goldilocks Zone: New Study Clarifies CD25’s Role in High-Risk AML, ALL

CD25 expression has long been recognized as an adverse prognostic marker in acute leukemias including acute myeloid leukemia ...
Yahoo Finance

2024 KOL Interview on Acute Myeloid Leukemia (AML) Treatment in Southern US: Expert Insights and Emerging Therapies - Magrolimab, Quizartinib, Crenolanib, Gilteritinib, and ...

Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) KOL Interview - US, South" report has been added to ResearchAndMarkets.com's offering. This report presents an exclusive ...
ITWire

iTWireTV Interview: Cabital's new Aussie AML Compliance Manager Luke Raven to help acquire regulatory approval in Australia

GUEST INTERVIEW: With anti money laundering (AML) and counter terrorism financing (CTF) management a vital part of any financial organisation, and especially so for crypto and digital assets companies ...
ITWire

VIDEO Interview: Cabital's new Aussie AML Compliance Manager Luke Raven to help acquire regulatory approval in Australia

GUEST INTERVIEW: With anti money laundering (AML) and counter terrorism financing (CTF) management a vital part of any financial organisation, and especially so for crypto and digital assets companies ...